GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (CHIX:MRKd) » Definitions » Other Operating Expense

Merck KGaA (CHIX:MRKD) Other Operating Expense : €827 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Other Operating Expense?

Merck KGaA's Other Operating Expense for the three months ended in Dec. 2024 was €326 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €827 Mil.

Merck KGaA's quarterly Other Operating Expense declined from Jun. 2024 (€311 Mil) to Sep. 2024 (€111 Mil) but then increased from Sep. 2024 (€111 Mil) to Dec. 2024 (€326 Mil).

Merck KGaA's annual Other Operating Expense increased from Dec. 2022 (€1,020 Mil) to Dec. 2023 (€1,046 Mil) but then declined from Dec. 2023 (€1,046 Mil) to Dec. 2024 (€828 Mil).


Merck KGaA Other Operating Expense Historical Data

The historical data trend for Merck KGaA's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Other Operating Expense Chart

Merck KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 841.00 760.00 1,020.00 1,046.00 828.00

Merck KGaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 725.00 79.00 311.00 111.00 326.00

Merck KGaA Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €827 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

No Headlines